1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow ASP4132: new trials by email Literature Review of ASP4132 trials Research Report on ASP4132
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma ASP4132 - Lymphoma, Refractory Solid Tumors | Phase 1 | Completed | Astellas Pharma Global Development, Inc. | 39 | 2015-03-23 | 2024-10-31 |
Lymphoma (1)
Astellas Pharma Global Development, Inc. (1)
United States (1)